《钱与血：亿万富豪、生物科技和突破性药物的探索之旅》[有声书]

English | ASIN: B0BRYJVS23 | 2023 | 8 hours and 33 minutes | MP3@64 kbps | 272 MB

A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives. For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses listeners in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction listen, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.

一本扣人心弦的商业叙事与科学惊悚小说，讲述了将一种奇迹药物推向市场所需的艰辛以及挽救无数生命的过程。《为血与钱》讲述了一个鲜为人知的故事：一家初创生物技术公司创造了一种罕见癌症药物，并且该核心团队在拒绝分享利润后再次做到了这一点。在这部关于金钱与科学的史诗般的传奇故事中，资深财经记者纳丁·瓦迪解释了两项历史上最大的癌症药物发明对于投资者而言成为有史以来最伟大的华尔街赌注的原因。在一个价值数十亿美元的生物技术行业中，制药公司、政府、对冲基金和风险投资家花费数以十亿计的资金用于融资、实验和治疗，而一个单一分子就能阻止癌症的发展——并让发现这种罕见分子的人变得异常富有。 《为血与钱》跟随一家加利福尼亚初创公司的小型团队，他们找到了其中的这些稀有分子之一。他们的化合物被称为BTK抑制剂，似乎对一种极其恶性的白血病有效。当病人开始从疗养院的床上站起来时，这个团队知道他们发现了大把机会。接下来是天才、悲情和戏剧的故事，在其中鲜活的人物穿梭于充满阴谋与模糊道德的世界中。瓦迪的叙事让听众沉浸在他的最近的生物技术初创公司热潮之中。他描述了科学家、医生以及投资者们为了开发新生命拯救药物而冒险的一切，同时也介绍了那些生命的 stakes 非常重要且生死攸关的患者。《为血与钱》是一部扣人心弦的非虚构听书作品，它阐释了为什么新的药物很难推向市场，解释它们为何如此昂贵，并探讨利润驱动的风险投资家如何塑造医学的未来。

---

Download from free file storage

 Download from rapidgator.net  Download from userupload.in  Download from nitroflare.com

---

我要反馈

---

本站不对文件进行储存，仅提供文件链接，请自行下载，本站不对文件内容负责，请自行判断文件是否安全，如发现文件有侵权行为，请联系管理员删除。